Progress in Neuro-Psychopharmacology and Biological Psychiatry, Год журнала: 2014, Номер 54, С. 265 - 274
Опубликована: Июль 3, 2014
Язык: Английский
Progress in Neuro-Psychopharmacology and Biological Psychiatry, Год журнала: 2014, Номер 54, С. 265 - 274
Опубликована: Июль 3, 2014
Язык: Английский
Nature Reviews Clinical Oncology, Год журнала: 2014, Номер 11(10), С. 597 - 609
Опубликована: Авг. 12, 2014
Язык: Английский
Процитировано
1256Clinical Psychology Review, Год журнала: 2013, Номер 33(6), С. 728 - 744
Опубликована: Май 14, 2013
Язык: Английский
Процитировано
283Clinical Psychology Review, Год журнала: 2013, Номер 34(2), С. 87 - 98
Опубликована: Дек. 20, 2013
Язык: Английский
Процитировано
245Brain Behavior and Immunity, Год журнала: 2014, Номер 42, С. 81 - 88
Опубликована: Июнь 11, 2014
Язык: Английский
Процитировано
198Neuroscience & Biobehavioral Reviews, Год журнала: 2016, Номер 74, С. 310 - 320
Опубликована: Май 11, 2016
Язык: Английский
Процитировано
173International Journal of Molecular Sciences, Год журнала: 2023, Номер 24(6), С. 5238 - 5238
Опубликована: Март 9, 2023
Post-traumatic stress disorder (PTSD) can become a chronic and severely disabling condition resulting in reduced quality of life increased economic burden. The is directly related to exposure traumatic event, e.g., real or threatened injury, death, sexual assault. Extensive research has been done on the neurobiological alterations underlying its phenotypes, revealing brain circuit disruption, neurotransmitter dysregulation, hypothalamic–pituitary–adrenal (HPA) axis dysfunction. Psychotherapy remains first-line treatment option for PTSD given good efficacy, although pharmacotherapy also be used as stand-alone combination with psychotherapy. In order reduce prevalence burden disorder, multilevel models prevention have developed detect early possible morbidity those established diseases. Despite clinical grounds diagnosis, attention increasing discovery reliable biomarkers that predict susceptibility, aid monitor treatment. Several potential linked pathophysiological changes PTSD, encouraging further identify actionable targets. This review highlights current literature regarding pathophysiology, disease development models, modalities, preventive from public health perspective, discusses state biomarker research.
Язык: Английский
Процитировано
51Molecular Psychiatry, Год журнала: 2015, Номер 20(12), С. 1538 - 1545
Опубликована: Март 10, 2015
Язык: Английский
Процитировано
175Neuroscience & Biobehavioral Reviews, Год журнала: 2016, Номер 69, С. 124 - 135
Опубликована: Июль 19, 2016
Язык: Английский
Процитировано
148Comprehensive physiology, Год журнала: 2014, Номер unknown, С. 715 - 738
Опубликована: Март 19, 2014
Evidence of aberrant hypothalamic-pituitary-adrenocortical (HPA) activity in many psychiatric disorders, although not universal, has sparked long-standing interest HPA hormones as biomarkers disease or treatment response. may be chronically elevated melancholic depression, panic disorder, obsessive-compulsive and schizophrenia. The axis more reactive to stress social anxiety disorder autism spectrum disorders. In contrast, is likely low PTSD atypical depression. Antidepressants are widely considered inhibit activity, inhibition unanimously reported the literature. There evidence, also uneven, that mood stabilizers lithium carbamazepine have potential augment measures, while benzodiazepines, antipsychotics, some extent, typical antipsychotics activity. Currently, most reliable use measures disorders predict likelihood relapse, changes been proposed play a role clinical benefits treatments. Greater attention patient heterogeneity consistent approaches assessing effects on function solidify value predicting response developing novel strategies manage disease.
Язык: Английский
Процитировано
142The Canadian Journal of Psychiatry, Год журнала: 2014, Номер 59(9), С. 468 - 479
Опубликована: Сен. 1, 2014
A large body of research has been produced in recent years investigating posttraumatic stress disorder (PTSD) among military personnel following deployment to Iraq and Afghanistan, resulting apparent differences PTSD prevalence. We compare prevalence estimates for current between subgroups, providing insight into how groups may be differentially affected by deployment. Systematic literature searches using the terms PTSD, disorder, acute stress, combined with relating personnel, identified 49 relevant papers. Studies a sample size less than 100 studies based on data treatment seeking or injured populations were excluded. categorized according theatre (Iraq Afghanistan), combat noncombat deployed samples, sex, enlistment type (regular reserve [or] National Guard), service branch (for example, army, navy, air force). Meta-analysis was used assess across subgroups. There variability studies, but, regardless heterogeneity, rates higher Iraq-deployed (12.9%; 95% CI 11.3% 14.4%), compared Afghanistan (7.1%; 4.6% 9.6%), serving Canadian, US, UK army navy marines (12.4%; 10.9% 13.4%), other services (4.9%; 1.4% 8.4%). Contrary findings from within-study comparisons, we did not find difference regular active-duty Guard personnel. Categorizing location subgroups that provide further support factors underlying development PTSD.
Язык: Английский
Процитировано
137